Angiotensin II - Receptor subtypes characterization and pathophysiological implications

Indian Journal of Experimental Biology

Volumn 34, Issue 2, 1996, Pages 91-97

  Gulati, Kavita ^a   Lall, Shyam Bala ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABUTAPRIL; ANGIOTENSIN RECEPTOR; CAPTOPRIL; LOSARTAN; SARALASIN; TALIPEXOLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ELECTROLYTE BALANCE; FLUID BALANCE; HEMODYNAMICS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0030024838     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Peach M J, Physiol Rev. 57 (1977) 313.
2. Ganten D, Fuxe K, Phillips M I, Mann J F E & Ganten U. in Frontiers in neuroendocrinology, edited by W F Ganong and L Martini (Raven Press. New York) 1978. 61.
3. Malvin R L, Fed Proc, 30 (1971) 1383.
4. Levens N R, Am J Physiol, 249 (1985) G3.
5. Moore T J & William G H, Circ Res, 51 (1982) 314.
6. Guillemettle G & Escher E, Biochemistry, 22 (1983) 5591.
7. Sen I. Bull H G & Soffer R L, Proc Natl Acad Sci. 116(1984) 1679.
8. Green D J. Am J Physiol, 253 (1987) F1.
9. De Gasparom & Levens N R, Kidney Int, 46 (1994) 1486.
10. Change R S & Lotti V J, Life Sci, 49 (1991) 1485.
11. Murphy T-J, Nature, 351 (1991) 233.
12. Elton T S, Stefan C C, Taylar G R, Kimball M G & Martin M M, Biochem Biophys Res Commun, 184 (1992) 1067.
13. Sandberg K, Ji H, Clark A J L, Shapira H & Catt K J, J Biol Chem, 267 (1992) 9455.
14. Bingham S J, Am J Physiol, 250 (1986) F759.
15. Hahn A W A, Jonas V, Buehler F R & Resink T J, Biochem Biophys Res Commun, 192 (1993) 1260.
16. Bingham S T, Am J Physiol. 250 (1986) F759.
17. Srivastava M B A, Biochem Pharmacol, 38 (1989) 489.
18. Kheterpal K, Lall S B, Rajdev S & Gupta Y K, Indian J Physiol Pharmacol, 30 (1986) 166.
19. Lall S B, Kheterpal K, Rajdev S & Gupta Y K, Indian J Physiol Pharmacol. 30 (1986) 145.
20. Rutledge D A, Smith L & Smith J B, Fed Proc. 44 (1985) 450 (Abst).
21. Smith J B, Smith L, Brown E R, Barnes D, Sarin M A, Davis J S & Farese R V, Proc Natl Acad Sci, 81 (1984) 7812.
22. Nishizuka Y, Nature, 308 (1984) 693.
23. Adelstein R S, Annu Rev Biochem, 49 (1980) 921.
24. Fleming J T & Joshua I G, Am J Physiol, 247 (1984) H88.
25. Catt K J, Harwood J P, Aguilera G & Dufau M L, Nature. 280 (1979) 109.
26. Sirett N E, Hubbard J I & Bray J J, Exp Brain Res, S4 (1982) 233.
27. Mann J F E, Schriffrin E L, Schiller P W, Boucher R & Genest J. in Central nervous system mechanisms in hypertension, edited. by Ferrano C M & Buckley J P (Raven Press, New York) 1980, 337.
28. Thomas W G & Sernia C, Brain Res, 345 (1985) 54.
29. Wilson K M, Magargal W & Berecek K H, Hypertension. Suppl 1 (1988) 1148.
30. Hollenberg N K, Chenitz W R, Adams D F & Williams G H. J Clin Invest, 54 (1974) 34
31. Aguilera G & Catt K J, Circ Res. 49 (1981) 751.
32. Platia M P, Latt K J, Modgen G D & Aguilera G, Hypertension, 8 (1986) 1121.
33. Millan M A, Carvello P, Izumi S, Zemel S, Katt K J & Aguilera G, Science. 244 (1989) 1340.
34. Duggan J, Nussberger J, Kilfeather S & O'Malley K, Am J Hypertens, 6 (1993) 641.
35. Lall S B, Peshin S S & Karmarkar M G, Indian J Physiol Pharmacol. 39 (1995) 51.
36. Kumar A, Lall S B, Ammini A, Peshin S S, Karmarkar M G, Talwar K K & Seth S D, J Human Hypertens, 8 (1994) 731.
37. Sato A, Suzuki H, Murakami M, Naka Zato Y, Iwaita Y & Saruta T, Hypertension, 23 (1994) 25.
38. Starte K, Rev Phystol Biochem Pharmacol. 77 (1977) 1.
39. Cline W H, J Pharmacol Exp Ther. 232 (1985) 661.
40. Majewski H, Hedler L, Schurr C & Starke K, J Cardiovasc Pharmacol, 6 (1984) 888.
41. De Jonge A, Knape J C, Van Meel J C A, Kalkmann H O, Wilffert B, Thoolen M J M C, Timmermans P B M W M & Van Zwieten P A, Naunyn Schmiedberg's Arch Pharmacol, 321 (1982) 309.
42. Ziogas J, Story D F & Rand M J, Clin Exp Phärmacol Physiol, 11 (1984) 413.
43. Xiang J Z, Linz W, Backers H, Ganten D, Lang R E, Scholkens B & Unger T, Eur J Pharmacol, 113 (1985) 215.
44. Gironacci M M, Adler G E, Pena C & Enero M A, Hypertension, 24 (1994) 457.
45. Mendelsohn F A O, Allen A M, Clevers J, Denton D A, Tarjan E & McKinley M J, J Comp Neurol, 270 (1988) 372.
46. Allen A M, Chai S Y, Clevers J, McKinley M J, Paxinos G & Mendelsohn F A O, J Comp Neurol, 269 (1988) 249.
47. Lewis S J, Allen A M, Verberne A J M, Figdor R, Jarrott B & Mendelsohn F A O, Eur J Pharmacol, 125 (1986) 305.
48. Reid I A, in Basic and clinical pharmacology, edited by B G Katzung (Prentice Hall International Inc), 1989, 217.
49. Hays R M, in The pharmacological basis of therapeutics, edited by A G Gilman, L S Goodman, T W Rall & F Murad (McMillan Publishing Co) 1985, 908.
50. Yamaguchi K, Hama H, Sakaguchi T, Negoro H & Kamoi K, Acta Endocrinol, 93 (1980) 407.
51. Catalioto R M, Renzetti A R, Criscuoli M, Mizrahi J & Subissi A, Eur J Pharmacol, 256 (1994) 93.
52. Mills I H, Mac Farlane N A A, Ward P E & Obika L F D, Fed Proc, 35 (1976) 181.
53. Margolius H S, Chao J & Kaizu T, Clin Sci Mol Med, 3 (suppl) (1976) 279s.
54. Rockman H A, Wachhorst S P, Mao L & Ross J, Am J Physiol, 226 (1994) H2468.
55. Smith T W, Braunwald E & Kelly R A, in Heart diseases, edited by E Braunwald (W B Saunders Co) 1992, 464.
56. Williams G H, in Harrisons principles of internal medicine, edited by K J Isselbacher, E Braunwald, J D Wilson, J B Martin, A S Fauda & D L Kasper (McGraw-Hill, Inc) 1994, 1116.
57. Lall S B, Dave V, Dash S C & Bhargava S, Angiology, 42(1991) 979.
58. McDonald W, Wicker C, Auman S, Ban D & Moffitt B, Endocrinology, 107 (1980) 1305.
59. Lall S B, Menon S M, Karmarkar M G, Siddiqui H N & Seth S D, Indian J Med Res. 92 (1990) 43.
60. Gutkind J S, Kurihara M & Saavedra J M, Am J Physiol, 255 (1988) H-646.
61. Lall S B, Peshin S S & Seth S D, J Hypertens, 8 (1990) 222 (Abst).
62. Lall S B, Siddiqui H H & Seth S D, Int J Toxicol Occup Environ Health, 2 (1993) 1.53 (Abst).
63. Peshin S S, Lall S B & Seth S D, Can J Physiol Pharmacol, 72 (suppl) (1994) 614 (Abst).
64. Lever A F, J Hypertension, 4 (1986) 515.
65. Reineck H J & Kreisberg J I, Kidney Int, 23 (1983) 247 (Abst).
66. Lall S B, Kunchaparty S, Siddiqui H H & Baaj J S, Acta Diabetol Lat, 27 (1990) 337.
67. Ballermann B J, Skorecki K L & Brenner B M, Am J Physiol, 247 (1984) F110.
68. Wilkes B M, Endocrinology, 120 (1987) 1291.
69. Kalinyak J E, Sechi L A, Griffin C A, Don A R, Tavangar K, Kraemer F B & Schambelan M, J Am Soc Nephrol, 4 (1993) 1337.
70. Marchant C, Brown L & Sernia C, J Cardiovasc, Pharmacol, 22 (1993) 449.
71. Wright J W, Miller A V, Shaffer M J, Higginson C, Wright D E, Hanseworth J M & Harding J W, Brain Res Bull. 32 (1993) 497.
72. Wright J W & Harding J W, Neurosci Biobehav Rev, 18(1994) 21.
73. Lingham T. Perlanski E & Grupp L A, Alcohol Clin Exp, 14 (1990) 92.